Volver a Agenda
Session Chair(s)
Jackie Kline, PHD
Vice President, Global Regulatory Affairs Oncology
Amgen, United States
Learning Objective : Discuss neglected tropical diseases including the serious health problems and economic burdens associated with these diseases; Identify the efforts of WHO and the Bill and Melinda Gates Foundation to control, eliminate, and eradicate these diseases; Describe the WHO Prequalification of Medicines Programme; Explain a recent example of the prequalification of diethylcarbamazine (DEC) for elimination of lymphatic filariasis.
Speaker(s)
WHO Perspective
Lembit Rago, DrMed, MD, PHD
Council for International Organizations of Medical Sciences (CIOMS), Switzerland
Secretary General
Challenges in Registering Products in Low- and Middle-Income Countries and What We Are Trying to Do With Various Partners
Murray M. Lumpkin, DrMed, MD, MSC
Bill and Melinda Gates Foundation, United States
Deputy Director, Integrated Development, Lead for Global Reg Systems Initiative
WHO Prequalification of Diethylcarbamazine for Elimination of Lymphatic Filariasis
Jackie Kline, PHD
Amgen, United States
Vice President, Global Regulatory Affairs Oncology
¿Tiene una cuenta?